Drug Shortage Report for NOZINAN
Report ID | 18692 |
Drug Identification Number | 01927698 |
Brand name | NOZINAN INJ 25MG/ML |
Common or Proper name | Nozinan solution injectable 25 mg/ml |
Company Name | NEURAXPHARM ARZNEIMITTEL GMBH |
Market Status | MARKETED |
Active Ingredient(s) | METHOTRIMEPRAZINE |
Strength(s) | 25MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 10 |
ATC code | N05AA |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2017-09-15 |
Actual start date | |
Estimated end date | 2017-11-03 |
Actual end date | 2017-11-09 |
Shortage status | Resolved |
Updated date | 2017-11-10 |
Company comments | Manufacturing delay |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | ELISABETH-SELBERT-STR. 23 LANGENFELD, GERMANY 40764 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-08-10 | English | Compare |
v2 | 2017-08-10 | French | Compare |
v3 | 2017-09-16 | English | Compare |
v4 | 2017-10-03 | English | Compare |
v5 | 2017-10-03 | French | Compare |
v6 | 2017-10-03 | English | Compare |
v7 | 2017-10-03 | French | Compare |
v8 | 2017-11-10 | English | Compare |
v9 | 2017-11-10 | French | Compare |
Showing 1 to 9 of 9